Pemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung Cancer
Condition(s):Non-Small Cell Lung CancerLast Updated:July 22, 2015Terminated
Hide Studies Not Open or Pending
Condition(s):Non-Small Cell Lung CancerLast Updated:July 22, 2015Terminated
Condition(s):Adenocarcinoma of Lung; Carcinoma, Non-Small-Cell LungLast Updated:January 25, 2024Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:June 24, 2022Recruiting
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:December 13, 2016Terminated
Condition(s):Colorectal Cancer MetastaticLast Updated:June 19, 2015Completed
Condition(s):Head and Neck CancerLast Updated:April 2, 2014Completed
Condition(s):Carcinoma, Non-Small-Cell Lung; Epidermal Growth Factor Receptor; Leptomeningeal MetastasisLast Updated:April 10, 2023Not yet recruiting
Condition(s):Head and Neck CancerLast Updated:February 10, 2020Completed
Condition(s):Non-small-cell Lung CancerLast Updated:September 29, 2011Completed
Condition(s):Lung Cancer, Non-Small CellLast Updated:November 17, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.